Early menopause linked to increased stroke and heart disease risk in global study

Women with early menopause face elevated risk of life-threatening cardiovascular events including heart attacks and strokes, with disproportionate impact on women in low-income countries.
When that protection vanishes at 40 instead of 50, you've lost a decade of that shield.
On how early menopause accelerates cardiovascular risk through loss of estrogen's protective effects.

A 15-year study spanning 111,000 women across 28 countries has placed the timing of menopause at the center of women's cardiovascular health, revealing that the earlier estrogen's protective presence fades, the greater the toll on the heart. Women who enter menopause before 40 carry a 27 percent higher risk of heart attack, stroke, or heart failure — a burden that falls with particular weight on women in low-income nations, where early menopause is nearly twice as common as in wealthy ones. The findings invite medicine to reconsider a biological transition long treated as a reproductive milestone and recognize it instead as a signal the whole body — and the whole healthcare system — must learn to read.

  • Women who lose estrogen's protection before age 40 face a 27% higher risk of heart attack, stroke, or heart failure — a danger that does not diminish even after accounting for diabetes, hypertension, or inactivity.
  • The risk is not distributed fairly: in Pakistan, Tanzania, Bangladesh, India, and Zimbabwe, nearly 43% of postmenopausal women entered menopause before 45, compared to just 23% in Canada, Sweden, and the UAE.
  • Estrogen does far more than govern reproduction — it regulates cholesterol, shields blood vessel walls, and holds visceral fat in check, so when it drops prematurely, atherosclerosis and metabolic decline can accelerate years ahead of schedule.
  • A methodological shadow complicates the picture: in low-income settings, malnutrition and physical exhaustion can halt menstruation without true menopause, potentially inflating early-onset figures in the world's poorest communities.
  • Experts are now calling for menopause history to become a standard cardiovascular risk marker — a responsibility shared across gynecology, cardiology, and primary care, not siloed within any single specialty.

A landmark study tracking more than 111,000 women across 28 countries over nearly 15 years has confirmed that the timing of menopause carries profound consequences for the heart. Women who entered menopause before age 40 faced a 27 percent higher risk of heart attack, stroke, or heart failure; those who crossed the threshold between 40 and 45 carried a 14 percent elevated risk. Published in The Lancet as part of the PURE study, the findings held firm across ethnic groups and income levels, even after controlling for established cardiovascular risk factors.

The mechanism runs through estrogen. That hormone does not merely govern reproduction — it keeps cholesterol and triglycerides in balance, maintains the integrity of blood vessel walls, and limits the accumulation of visceral fat. When estrogen drops prematurely, the biological scaffolding that protects against atherosclerosis and metabolic deterioration begins to fail years earlier than it otherwise would.

The burden is not shared equally. In South Asia and sub-Saharan Africa, nearly 43 percent of postmenopausal women reported entering menopause before age 45 — nearly double the rate seen in high-income nations. Women in South Asia faced a 34 percent higher risk of premature menopause compared to European women, and their median age at menopause was more than three years younger. Researchers noted that chronic malnutrition can cause menstruation to cease without true menopause, which may partially inflate these figures — but does not erase the underlying risk.

The clinical implications are clear: early menopause should become a recognized cardiovascular risk marker, prompting coordinated screening across gynecology, cardiology, and primary care. Lifestyle measures remain the foundation of prevention, while hormone replacement therapy warrants case-by-case evaluation. Earlier research from JAMA Cardiology had already shown that Black women in the United States are three times more likely to enter menopause before 40 than other groups — a disparity the PURE study now situates within a global pattern of inequity that medicine can no longer afford to overlook.

A sweeping study that tracked more than 111,000 women across 28 countries over nearly 15 years has confirmed what researchers suspected but now can quantify: when menopause arrives early, the heart pays the price. Women who entered menopause before age 40 faced a 27 percent higher risk of heart attack, stroke, or heart failure. Those who crossed that threshold between 40 and 45 carried a 14 percent elevated risk. The findings, published in The Lancet Obstetrics, Gynaecology, & Women's Health as part of the PURE study, suggest that the timing of menopause itself—not just the condition of being postmenopausal—matters profoundly for cardiovascular health.

The research team recruited women between 2005 and 2016, with an average age of 50.6 years at enrollment. Roughly 43 percent lived in rural areas. Researchers used standardized questionnaires and followed participants for a median of 14.6 years, applying statistical models that accounted for age and established cardiovascular risk factors. The consistency of the finding across different ethnic groups and income levels lent it weight: the association between early menopause and cardiovascular danger held even after controlling for traditional risk factors like high blood pressure, diabetes, and physical inactivity.

The biology underlying this pattern centers on estrogen. As menopause approaches, estrogen levels plummet. That hormone does more than regulate reproduction—it helps keep cholesterol and triglycerides in check, maintains the health of blood vessel walls, and prevents the buildup of visceral fat. When that hormonal shield drops prematurely, atherosclerosis can accelerate, metabolism can deteriorate, and the machinery that protects against heart attacks and strokes begins to fail earlier than it otherwise would.

But the story does not distribute evenly across the world. Women in low-income and middle-income countries experienced early or premature menopause at significantly higher rates than their counterparts in wealthy nations. In Pakistan, Tanzania, Bangladesh, India, and Zimbabwe, nearly 43 percent of postmenopausal women reported entering menopause before age 45. In Canada, Saudi Arabia, Sweden, and the United Arab Emirates, that figure dropped to 23 percent. Women in South Asia faced a 34 percent higher risk of premature menopause compared to European women. The median age at menopause in South Asia was 47.4 years; in Europe, 50.7 years.

Researchers flagged an important caveat: in low-income settings, chronic malnutrition and physical exhaustion can trigger amenorrhea—the cessation of menstruation—through physiological stress alone, not through true menopause. When health surveys record this absence of periods, they may misclassify it as menopause. This methodological blur could partially inflate the gap between wealthy and poor countries, though the researchers emphasized it does not erase the fundamental link between genuinely early menopause and cardiovascular danger.

The implications ripple across healthcare systems. Women with premature or early menopause should become a priority population for cardiovascular screening and prevention, experts argue. That responsibility does not belong to gynecologists alone. Cardiologists and primary care physicians need to know a woman's menopause history and adjust their surveillance accordingly. Concrete preventive measures—maintaining a healthy weight, not smoking, exercising regularly, eating well—remain central. Hormone replacement therapy emerged as one tool worth evaluating on a case-by-case basis, though lifestyle change remains the foundation.

This research builds on earlier work. A study published in JAMA Cardiology found that premature menopause correlated with long-term coronary artery disease in American women followed over decades. That research revealed a stark disparity: Black women were three times more likely to enter menopause before age 40 than other groups. Cardiologist Priya Freaney, who led that work, emphasized that knowing when menopause begins helps clinicians calculate a woman's cumulative lifetime risk and tailor prevention strategies accordingly. The PURE study, with its global scope and long follow-up, now provides the broader evidence base for that clinical intuition.

Estrogen helps keep cholesterol and triglycerides in check, maintains blood vessel health, and prevents dangerous fat accumulation. When that protection drops prematurely, atherosclerosis can accelerate and cardiovascular damage begins earlier.
— Francisco Carmona, director of endometriosis unit at Hospital Clínic Barcelona, explaining the biological mechanism
Knowing the age of menopause onset helps clinicians calculate a woman's cumulative lifetime risk and tailor prevention strategies accordingly.
— Cardiologist Priya Freaney, on the clinical importance of menopause timing
The Hearth Conversation Another angle on the story
Inventor

Why does the timing of menopause matter so much for the heart? Couldn't a woman just manage her cardiovascular risk the same way at 42 as at 52?

Model

The difference is in how long the body has been without estrogen's protection. Estrogen does real work—it keeps cholesterol down, maintains blood vessel health, prevents dangerous fat from accumulating around organs. When that protection vanishes at 40 instead of 50, you've lost a decade of that shield. The damage compounds over time.

Inventor

The study mentions that malnutrition and stress in poor countries might be triggering false menopause—women whose periods stop from hardship, not hormones. How much does that muddy the findings?

Model

It's a real problem, but the researchers were honest about it. They said it might partially inflate the gap between rich and poor countries, but it doesn't erase the core finding. Even accounting for that confusion, early menopause still predicts cardiovascular danger. The gap is real, even if some of it is measurement error.

Inventor

So what should a woman do if she's 38 and her periods stop? Rush to a cardiologist?

Model

Not necessarily rush, but yes—get clarity on what's happening. Is it true menopause or stress-induced amenorrhea? Once you know, you have a roadmap. If it's genuine early menopause, then yes, cardiovascular screening becomes important. And the basics matter: don't smoke, move your body, eat well, keep your weight stable. Those aren't glamorous, but they're powerful.

Inventor

The study found the risk persisted even after adjusting for traditional factors like diabetes and high blood pressure. What does that tell us?

Model

It means early menopause carries its own independent danger signal. It's not just that women with early menopause happen to have more diabetes. The menopause itself—the loss of estrogen—is doing damage that standard risk factors don't fully capture. That's why doctors need to treat it as its own red flag.

Contact Us FAQ